Last checked at 19 Jan 2021 07:00
REACH
Feedback plc
BleepaⓇ builds on robust data management security
· Cyber Essentials Plus Certified
· ISO 27001 compliant
London, 19 January 2021: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, today announces it has bolstered its data management security with certification of Cyber Essentials Plus and ISO 27001 for its flagship imaging-based communication platform, Bleepa. The enhanced data management protection will provide customers and clinicians with added confidence in the safety of Bleepa's data security.
Bleepa, a secure instant messaging platform which facilitates the sharing of clinical grade medical images between personal devices, is an essential tool to enable remote and secure communications between clinicians and their teams. Security of data is of the utmost importance for remote communications and Feedback continuously reviews and updates its security to comply with international standards.
The Cyber Essentials Plus audit is a UK Government backed scheme to enable organisations to guard against a whole range of the most common cyber-attacks and demonstrates a commitment to cyber security.
ISO 27001 is the international standard that sets out the specification for an information security management system (ISMS). Its best-practice approach helps organisations manage their information security by addressing people and processes as well as technology.
Both certificates are sought by the Company's healthcare customers and will bolster customer confidence in the security of the Bleepa platform.
Dr Tom Oakley, CEO of Feedback, commented:
"Feedback seeks to liberate frontline clinicians from inadequate, cumbersome operational systems by safely simplifying how they communicate with each other and how they access information about patients, most notably medical imaging. The emphasis here is on safety. As a medical device manufacturer, we already adhere to stringent quality processes that comply with ISO 13485, however, being a digital medical device brings new challenges to safety and quality that are not reflected in traditional medical device certification. We have sought to address these challenges and demonstrate our commitment to data security as rigorously as the processes which we apply to ensuring quality. Cyber Essentials Plus and ISO 27001 confirm the security of Bleepa as a platform just as ISO 13485 confirms the quality and safety of its manufacture. This combined certification is testament to our commitment to providing clinicians with the right tools for the job and will give customers confidence about the security of data on the platform."
-Ends-
Enquiries:
Feedback plc Tom Oakley, CEO Lindsay Melvin, CFO | +44 (0) 20 3997 7634 IR@fbk.com |
Allenby Capital Limited (Nominated Adviser) David Worlidge / Asha Chotai | +44 (0)20 3328 5656 |
Walbrook PR Ltd | Tel: 020 7933 8780 or feedbackplc@walbrookpr.com |
Paul McManus/Nick Rome/Nicholas Johnson | 07980 541 893 or 07748 325 236 or 07884 664 686 |
Notes to editors
Feedback plc (AIM: FDBK) is a medical imaging technology business. Its core product, Bleepa, is a revolutionary medical imaging communications app, providing an easy-to-use, high quality tool to enable remote and secure communications between front-line clinicians and teams. Importantly, it is the only CE marked medical imaging communications platform on the NHSx clinical communications tools framework. Bleepa has unparalleled functionality for everyday practice and can be accessed from any internet-connected device, enabling control of patient cases when on the go.
Its highly scalable Software as a Service ("SaaS") based revenue model will provide increasing levels of visibility as the Company grows its customer base. With a growing distribution base and technology in place, the focus is on leveraging key relationships in order to drive sales both in the UK and internationally to all forms of care facilitators. As a fully certified medical device, Bleepa aims to disrupt the medical imaging communications market and, importantly, increase the accuracy and speed of diagnosis.
About Reach announcements
This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.